GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyePoint Pharmaceuticals Inc (FRA:PV3B) » Definitions » Other Assets for Insurance Companies

EyePoint Pharmaceuticals (FRA:PV3B) Other Assets for Insurance Companies


View and export this data going back to . Start your Free Trial

What is EyePoint Pharmaceuticals Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


EyePoint Pharmaceuticals (FRA:PV3B) Business Description

Industry
Traded in Other Exchanges
Address
480 Pleasant Street, Suite B300, Watertown, MA, USA, 02472
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.